LSL Pharma Group Inc.
LSL.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.21M | -283.00K | -377.10K | -207.70K | -933.50K |
| Total Depreciation and Amortization | 339.30K | 259.50K | 252.90K | 247.70K | 179.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.00M | 345.30K | 567.10K | 340.40K | 2.46M |
| Change in Net Operating Assets | -230.70K | -385.70K | -521.10K | -1.80M | -1.69M |
| Cash from Operations | 322.90K | -63.80K | -78.20K | -1.42M | 9.60K |
| Capital Expenditure | 764.40K | -876.90K | -678.90K | -402.80K | -89.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -800.10K | -22.00K | -1.54M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.49M | -122.40K | -148.40K | -108.30K | -228.60K |
| Cash from Investing | -1.53M | -1.02M | -2.37M | -511.00K | -318.30K |
| Total Debt Issued | 6.24M | 1.76M | 438.00K | 1.26M | 787.00K |
| Total Debt Repaid | -3.89M | -957.00K | -1.17M | -440.00K | -1.17M |
| Issuance of Common Stock | 0.00 | 960.00K | 5.29M | 1.99M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -530.00K | -403.00K | -889.00K | -245.00K | 841.00K |
| Cash from Financing | 1.30M | 993.50K | 2.68M | 1.90M | 336.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.30K | -91.60K | 235.30K | -30.40K | 27.90K |